Journalists

Media & Press relations

Our latest press releases

January 16, 2024

bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D

bioMérieux, a world leader in the field of in vitro diagnostics, announces the appointment of two new Executive Committee members: Dr. Charles K. Cooper as Executive Vice President, Chief Medical Officer, effective January 2nd, 2024; Céline Roger-Dalbert as Executive Vice President Research and Development, effective March 1st, 2024.

Discover more

Swipe for more

January 08, 2024

bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance

bioMérieux, a world leader in the field of in vitro diagnostics, announces the acquisition of LUMED, a software company that has developed a clinical decision support system to help hospitals optimize antimicrobial prescriptions and monitor healthcare-associated infections.

Read more
October 26, 2023

Third-Quarter 2023 Business Review

bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the nine months ended September 30, 2023. Consolidated sales amounted to €2,668 million for the first nine months of 2023.

Read more
October 19, 2023

bioMérieux makes strategic investment in Oxford Nanopore

Oxford Nanopore Technologies plc (LSE: ONT) (“Oxford Nanopore”), the company delivering a new generation of nanopore-based molecular sensing technology, and bioMérieux SA, a world leader in the field of in vitro diagnostics (“IVD”) today announce that bioMérieux is making an immediate £70M investment in Oxford Nanopore.

Read more